OSCR Oscar Health, Inc.

NYSE hioscar.com


$ 14.19 $ -0.51 (-3.47 %)    

Thursday, 13-Nov-2025 13:11:13 EST
QQQ $ 608.99 $ -8.64 (-1.4 %)
DIA $ 477.59 $ -3.76 (-0.78 %)
SPY $ 674.04 $ -6.43 (-0.94 %)
TLT $ 89.59 $ -0.21 (-0.23 %)
GLD $ 386.47 $ -0.79 (-0.2 %)
$ 15.1
$ 14.70
$ 14.18 x 520
$ 14.20 x 214
$ 14.18 - $ 14.93
$ 11.20 - $ 23.80
9,731,627
na
4B
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 02-20-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-15-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 02-24-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-13-2021 06-30-2021 10-Q
19 05-14-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wells-fargo-maintains-underweight-on-oscar-health-lowers-price-target-to-11

Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Underweight and lowers the price target from $1...

 barclays-maintains-underweight-on-oscar-health-raises-price-target-to-13

Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Underweight and raises the price target from $11 to $13.

 oscar-health-expands-affordable-tech-powered-plans-across-south-florida-for-2026-enrollment

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, today is introducing affordable, tec...

 ubs-maintains-sell-on-oscar-health-raises-price-target-to-12

UBS analyst Jonathan Yong maintains Oscar Health (NYSE:OSCR) with a Sell and raises the price target from $11 to $12.

 new-leverage-shares-etfs-let-traders-go-2x-on-lululemon--and-other-companies

New Leverage Shares ETFs allow investors double daily returns on Lululemon, Gemini, and Oscar Health at one of the lowest fees ...

 oscar-health-misses-q3-revenue-loss-widens-to-129-million-despite-membership-surge

Oscar Health's Q3 revenue rose to $2.99 billion on higher membership, but losses widened as risk adjustments offset gains.

 ai-stocks-slide-again-bitcoin-dips-near-100000-whats-moving-markets-thursday

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading...

 oscar-health-affirms-fy2025-sales-guidance-of-12000b-12200b-vs-12039b-est

Oscar Health (NYSE:OSCR) affirms FY2025 sales outlook from $12.000 billion-$12.200 billion to $12.000 billion-$12.200 billion v...

 oscar-health-q3-eps-053-beats-061-estimate-sales-2986b-miss-3082b-estimate

Oscar Health (NYSE:OSCR) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.61) by...

 oscar-health-rolling-out-different-health-plans-for-individuals-families-businesses-throughout-orlando

Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, today is introducing affordable, tec...

 centene-and-oscar-health-stocks-sink-after-molina-warning

US healthcare insurance providers Centene and Oscar Health stocks are down after Molina Healthcare reported disappointing guida...

 goldman-sachs-initiates-coverage-on-oscar-health-with-neutral-rating-announces-price-target-of-17

Goldman Sachs analyst Scott Fidel initiates coverage on Oscar Health (NYSE:OSCR) with a Neutral rating and announces Price ...

 wells-fargo-maintains-underweight-on-oscar-health-raises-price-target-to-14

Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Underweight and raises the price target from $1...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION